Medicinal product name Oprymea
Pharmaceutical form Prolonged-release tablet
Strength 1.05 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/08/469/035 KZSLN30 Is available
Legal status Rx Prescription (Pr.)
KZSL Next lowest cost medicine
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code N04BC05 Anti-parkinson drugs

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(247 containers)
Tamro, Recipe Plus, Magnum Medical N30
(1,05 mg)
OPA/Al/PE/desiccant/Al blister 26.81 
KZSL*
EU/1/08/469/035  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/08/469/035
Date of authorisation Sep 12, 2008
Marketing authorisation holder, country KRKA, d.d., Novo mesto, Slovenia